Blood Purification
Original Paper
Emergent Start Peritoneal Dialysis for End-Stage Renal Disease: Outcomes and AdvantagesNayak K.S. · Subhramanyam S.V. · Pavankumar N. · Antony S. · Sarfaraz Khan M.A.Department of Nephrology, Deccan Hospital, Hyderabad, India
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: November 14, 2017
Accepted: December 29, 2017
Published online: January 30, 2018
Issue release date: April 2018
Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 3
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Abstract
Background/Aims: Initiating renal replacement therapy in late referred patients with central venous catheter (CVC) hemodialysis (HD) causes serious complications. In urgent start peritoneal dialysis, initiating peritoneal dialysis (PD) within 14 days of catheter insertion still needs HD with CVC. We initiated Emergent start PD (ESPD) with Automated PD (APD) at our center within 48 h from the time of presentation. Methods: A prospective, case-controlled, intention-to-treat study with 56 patients was conducted between March 2016 and August 2017. Group A (24 patients) underwent conventional PD 14 days after catheter insertion. Group B (32 patients), underwent ESPD with APD. Exit site leak (ESL), catheter blockage, and peritonitis at 90 days were primary outcomes. Technique survival was secondary outcome. Results: Baseline characteristics were similar with 3 episodes of ESLs (9.4%) in the study group and none in the control group (p = 0.123). Catheter blockage (16.7%-Group A, 25%-Group B) and peritonitis (none vs. 9.4% in study group) were similar in terms of statistical details just as technique survival (95%-Group A, 88.2%-Group B at 90 days). Conclusion: ESPD with APD in the unplanned patient is an appropriate approach.
© 2018 S. Karger AG, Basel
Related Articles:
References
- Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H, Hu Y, Kats A, Li S, Li S, Maloney J, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Johnson R, Sheets D, Wang X, Forrest B, Berrini D, Constantini E, Everson S, Eggers P, Agodoa L: US Renal Data System 2012 annual data report. Am J Kidney Dis 2013; 61(suppl 1):1–480.
- Xue H, Ix JH, Wang W, Brunelli SM, Lazarus M, Hakim R, Lacson E Jr: Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications. Am J Kidney Dis 2012; 61: 123–130.
- Perl J, Wald R, McFarlane P, Bargman JM, Vonesh E, Na Y, Jassal SV, Moist L: Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol 2011; 22: 1113–1121.
- Oliver MJ, Verrelli M, Zacharias JM, Blake PG, Garg AX, Johnson JF, Pandeya S, Perl J, Kiss AJ, Quinn RR: Choosing peritoneal dialysis reduces the risk of invasive access interventions. Nephrol Dial Transplant 2012; 27: 810–816.
- Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J: Type of vascular access and survival among incident hemodialysis patients: the choices for healthy outcomes in caring for ESRD (CHOICE) study. J Am Soc Nephrol 2005; 16: 1449–1455.
- Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, Bannister KM, Wiggins KJ: Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis 2009; 53: 290–297.
- Ishani A, Collins AJ, Herzog CA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: the USRDS wave 2 study. Kidney Int 2005; 68: 311–318.
- Patel PR, Kallen AJ, Arduino MJ: Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients. Am J Kidney Dis 2010; 56: 566–577.
- Koch M, Kohnle M, Trapp R, Haastert B, Rump LC, Aker S: Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis. Nephrol Dial Transplant 2012; 27: 375–380.
- Tam P: Peritoneal dialysis and preservation of residual renalfunction. Perit Dial Int 2009; 2(suppl 2):108–110.
- Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556–564.
- Blagg CR: Dialysis composite rate bundling: potential effects on the utilization of home hemodialysis, daily and nocturnal hemodialysis, and peritoneal dialysis. Semin Dial 2011; 24: 674–677.
- Klarenbach S, Manns B: Economic evaluation of dialysis therapies. Semin Nephrol 200929: 524–532.
- Golper TA, Saxena AB, Piraino B, Teitelbaum I, Burkart J, Finkelstein FO, Abu-Alfa A: Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis. Am J Kidney Dis 2011; 58: 879–885.
- See EJ, Cho Y, Hawley CM, Jaffrey LR, Johnson DW: Early and late patient outcomes in urgent-start peritoneal dialysis. Perit Dial Int 2017; 37: 414–419.
- Masseur A, Guest S, Kumar V: Early technique success after initiation of treatment with urgent-start peritoneal dialysis. Adv Perit Dial 2014; 30: 36–39.
- Arramreddy R, Zheng S, Saxena AB, Liebman SE, Wong L: Urgent-start peritoneal dialysis: a chance for a new beginning. Am J Kidney Dis 2014; 63: 390–395.
- Casaretto A, Rosario R, Kotzker WR, Pagan-Rosario Y, Groenhoff C, Guest S: Urgent-start peritoneal dialysis: report from a U.S. private nephrology practice. Adv Perit Dial 2012; 28: 102–105.
- Ghaffari A: Urgent-start peritoneal dialysis: a quality improvement report. Am J Kidney Dis 2012; 59: 400–408.
- Lobbedez T, Lecouf A, Ficheux M, Henri P, Hurault de Ligny B, Ryckelynck JP: Is rapid initiation of peritoneal dialysis feasible in unplanned dialysis patients? A single-centre experience. Nephrol Dial Transplant 2008; 23: 3290–3294.
- Ivarsen P, Povlsen JV: Can peritoneal dialysis be applied for unplanned initiation of chronic dialysis? Nephrol Dial Transplant 2014; 29: 2201–2206.
- Song JH, Kim GA, Lee SW, Kim MJ: Clinical outcomes of immediate full-volume exchange one year after peritoneal catheter implantation for CAPD. Perit Dial Int 2000; 20: 194–199.
- Li PK, Szeto CC, Piraino B, Arteaga J, Fan S, Figueiredo AE: ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int 2016; 36: 481–508.
- Ranganathan D, John GT, Yeoh E, Williams N, O’Loughlin B, Han T, Jeyaseelan L, Ramanathan K, Healy H: A randomized controlled trial to determine the appropriate time to initiate peritoneal dialysis after insertion of catheter (Timely PD study). Perit Dial Int 2017; 37: 420–428.
- Crabtree JH, Burchette RJ: Peritoneal dialysis access and start practices that affect dialysate leak and technique failure: acts of commission and omission. Perit Dial Int 2017; 37: 358–361.
- Povlsen JV, Ivarsen P: How to start the late referred ESRD patient urgently on chronic APD. Nephrol Dial Transplant 2006;(suppl 2): 56–59.
Article / Publication Details
Received: November 14, 2017
Accepted: December 29, 2017
Published online: January 30, 2018
Issue release date: April 2018
Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 3
ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)
For additional information: https://www.karger.com/BPU
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
